title: Bevacizumab in the treatment of non-small cell lung cancer: focus on East Asia.
authors.forename: Tony S K
authors.initials: TS
authors.lastname: Mok
mesh_terms: D006801:Humans; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D005202:Asia, Eastern; D000068258:Bevacizumab; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab